Clinical outcomes for ulcerative colitis patients with a prior anti-TNF therapy failure appeared similar with ustekinumab ...
A study revealed that IBD patients, particularly those with ulcerative colitis and multiple biologic treatments, face an ...
Investor's Business Daily on MSN2d
AnaptysBio Whipsaws On Promising Results In Rheumatoid Arthritis TreatmentAnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.
Ulcerative colitis is a chronic, immune-mediated disorder of the colon and rectum characterized by mucosal inflammation that damages the bowel wall surface. Current therapeutic options include ...
Palisade Bio (PALI) announced the presentation of positive preclinical data from PALI-2108, an orally administered, colon-specific ...
Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...
Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, ...
Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...
The Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) are excited to host the annual Crohn’s & Colitis Congress®, taking place Feb. 6-8, in San Francisco, CA. This ...
This can happen in response to effective treatments for microscopic colitis. Remission is the primary goal of microscopic colitis treatment. A 2022 systematic review and meta-analysis looked at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback